NAV
₹39.7889
as of 31 Jul 2026
Expense Ratio
—
see scheme documents
Viewing Direct · Growth
Lumpsum returns (CAGR)
- 1Y
- +9.52%
- 3Y
- +21.09%
- 5Y
- +15.41%
- Since Inception
- +13.93%
SIP returns (XIRR)
- 1Y
- +21.82%
- 3Y
- +17.04%
- 5Y
- +19.15%
- Since Inception
- +18.45%
Performance Comparison
Thinking about Tata India Pharma and Healthcare Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Compare All Sectoral / Thematic FundsView all Sectoral / Thematic funds
Fund Details
Fund HouseTata Mutual Fund
CategorySectoral / Thematic
Launch Date28 Dec 2015
AMFI Code135810
Transaction facts
Min. Lumpsum₹5,000
Min. SIP₹100
Exit LoadCurrent load structure(w.e.f.18/04/2016): Exit Load: 1% if redeemed on or before expiry of 365 days from the date of allotment. Exit load for investment will be as applicable as on the date of allotment / date of registration in case of SIP and STP
Available transactions
PurchaseSIPRedeemSWPSwitchSTPDemat
Portfolio holdings
as of 30 Jun 2026
portfolio shared with Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Holding% NAV
- 1Sun Pharmaceutical Industries Ltd8.51%
- 2Max Healthcare Institute Ltd5.68%
- 3Healthcare Global Enterprises Ltd5.52%
- 4Divi Laboratories Ltd5.12%
- 5Abbott India Ltd4.97%
- 6Cipla Ltd4.77%
- 7Apollo Hospitals Enterprise Ltd4.61%
- 8Rainbow Childrens Medicare Ltd4.42%
- 9Dr Reddys Laboratories Ltd4.26%
- 10Glaxosmithkline Pharmaceuticals Ltd4.12%
Rows per page· 34 total
Page 1/4
Investment Objective
Tata India Pharma and Healthcare Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Tata India Pharma and Healthcare Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by Tata Mutual Fund. The fund has been operational for over 10 years.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations